J J Gibbons

1.2k total citations
24 papers, 987 citations indexed

About

J J Gibbons is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, J J Gibbons has authored 24 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in J J Gibbons's work include T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer therapeutics and mechanisms (3 papers). J J Gibbons is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer therapeutics and mechanisms (3 papers). J J Gibbons collaborates with scholars based in United States, United Kingdom and Ireland. J J Gibbons's co-authors include Susan Quinn DeJoy, John M. Fidler, Philip Frost, Jerauld S. Skotnicki, Lourdes Toral‐Barza, Carolyn Discafani, Ker Yu, Brian J. O’Hara, S V Johann and Victor B. Hatcher and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

J J Gibbons

23 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J J Gibbons United States 13 445 250 220 185 128 24 987
J Fujimoto Japan 16 282 0.6× 152 0.6× 253 1.1× 92 0.5× 65 0.5× 30 897
Hiroyoshi Hattori Japan 17 435 1.0× 310 1.2× 325 1.5× 57 0.3× 126 1.0× 39 989
A. Wunderlich Germany 14 226 0.5× 158 0.6× 238 1.1× 65 0.4× 73 0.6× 21 791
Omid Rasool Sweden 28 666 1.5× 312 1.2× 584 2.7× 281 1.5× 182 1.4× 62 1.9k
A Hizuta Japan 16 483 1.1× 466 1.9× 282 1.3× 85 0.5× 146 1.1× 62 1.1k
S. Kishimoto Japan 19 349 0.8× 170 0.7× 575 2.6× 140 0.8× 77 0.6× 61 1.5k
Stéphan Ellmerich United Kingdom 17 642 1.4× 185 0.7× 253 1.1× 69 0.4× 86 0.7× 22 1.1k
Heidrun Recheis Austria 10 370 0.8× 102 0.4× 365 1.7× 247 1.3× 79 0.6× 12 917
Timothy C. Rodell United States 17 328 0.7× 202 0.8× 329 1.5× 67 0.4× 58 0.5× 36 1.2k
Anna Vossenkämper United Kingdom 20 473 1.1× 113 0.5× 494 2.2× 106 0.6× 206 1.6× 28 1.2k

Countries citing papers authored by J J Gibbons

Since Specialization
Citations

This map shows the geographic impact of J J Gibbons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J J Gibbons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J J Gibbons more than expected).

Fields of papers citing papers by J J Gibbons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J J Gibbons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J J Gibbons. The network helps show where J J Gibbons may publish in the future.

Co-authorship network of co-authors of J J Gibbons

This figure shows the co-authorship network connecting the top 25 collaborators of J J Gibbons. A scholar is included among the top collaborators of J J Gibbons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J J Gibbons. J J Gibbons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarthy, Claire E., J J Gibbons, Sarah H. Chung, et al.. (2024). Germline variant profiling of CHEK2 sequencing variants in breast cancer patients. Cancer Genetics. 288-289. 10–19.
2.
Wakelee, Heather A., George Blumenschein, Karen L. Reckamp, et al.. (2016). Phase I/II trial of X-396 in patients (pts) with ALK+ non-small cell lung cancer (NSCLC): Correlation with plasma and tissue genotyping and response to therapy (tx). Annals of Oncology. 27. vi419–vi419. 4 indexed citations
3.
Horn, Leora, Heather A. Wakelee, Tobias Arkenau, et al.. (2014). A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors. International Journal of Radiation Oncology*Biology*Physics. 90(5). S52–S53. 5 indexed citations
4.
Brell, Joanna M., Joseph A. Bokar, Matthew M. Cooney, et al.. (2008). Phase I study of sunitinib malate continuously dosed and standard-infusion gemcitabine in solid tumors. Journal of Clinical Oncology. 26(15_suppl). 13533–13533. 2 indexed citations
5.
Yu, Ker, Lourdes Toral‐Barza, Carolyn Discafani, et al.. (2001). mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.. Endocrine Related Cancer. 8(3). 249–258. 354 indexed citations
6.
Yao, Lei, et al.. (1995). Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infection and Immunity. 63(5). 1835–1839. 99 indexed citations
7.
Gibbons, J J, et al.. (1993). Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans. Clinical & Experimental Immunology. 92(1). 169–173. 39 indexed citations
8.
Eckhardt, Thomas, et al.. (1993). Biochemical and immunological properties of two forms of pertactin, the 69,000-molecular-weight outer membrane protein of Bordetella pertussis. Infection and Immunity. 61(5). 2211–2215. 24 indexed citations
9.
Gibbons, J J, et al.. (1992). Discharge Criteria For Outpatients Following Axillary Brachial Plexus Blockade. Anesthesiology. 77(Supplement). A47–A47. 7 indexed citations
10.
Gibbons, J J, Raul O. Parra, G.L. Andriole, & Frank E. Johnson. (1992). Testicular circulatory isolation: a Phase I study. Surgical Oncology. 1(6). 413–416. 3 indexed citations
11.
Johann, S V, J J Gibbons, & Brian J. O’Hara. (1992). GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. Journal of Virology. 66(3). 1635–1640. 129 indexed citations
12.
Praloran, Vincent, et al.. (1990). Alterations in the expression of colony-stimulating factor-1 and its receptor during an acute graft-vs-host reaction in mice.. The Journal of Immunology. 145(10). 3256–3261. 15 indexed citations
13.
Gibbons, J J. (1989). Treatment of missile injuries of the chest: Belfast experience. European Journal of Cardio-Thoracic Surgery. 3(4). 297–299. 7 indexed citations
14.
Gibbons, J J & Judy Lucas. (1989). Immunomodulation by low-dose methotrexate. I. Methotrexate selectively inhibits Lyt-2+ cells in murine acute graft-versus-host reactions.. The Journal of Immunology. 142(6). 1867–1873. 13 indexed citations
15.
Mellon, J.K., et al.. (1988). Oesophago-pericardial fistula and cardiac tamponade after oesophagoscopy. European Journal of Cardio-Thoracic Surgery. 2(4). 282–283. 3 indexed citations
16.
Gualtieri, RJ, et al.. (1988). Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia.. PubMed. 16(7). 613–9. 14 indexed citations
17.
Fidler, John M., et al.. (1986). Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.. The Journal of Immunology. 136(8). 2747–2754. 91 indexed citations
18.
Reinus, John F., et al.. (1985). Metabolic balance in human volunteers fed diets containing ethanol by continuous infusion through a nasogastric tube. Hepatology. 5(5). 1033. 11 indexed citations
19.
Goidl, E A, Judy Choy, J J Gibbons, et al.. (1983). Production of auto-antiidiotypic antibody during the normal immune response. VII. Analysis of the cellular basis for the increased auto-antiidiotype antibody production by aged mice.. The Journal of Experimental Medicine. 157(5). 1635–1645. 26 indexed citations
20.
Moody, Charles E., et al.. (1983). Studies on the syngeneic mixed lymphocyte reaction. III. Development of a monoclonal antibody with specificity for autoreactive T cells.. The Journal of Experimental Medicine. 158(4). 1307–1318. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Fujimoto Breakdown of academic impact, for papers by Hiroyoshi Hattori Breakdown of academic impact, for papers by A. Wunderlich Breakdown of academic impact, for papers by Omid Rasool Breakdown of academic impact, for papers by A Hizuta Breakdown of academic impact, for papers by S. Kishimoto Breakdown of academic impact, for papers by Stéphan Ellmerich Breakdown of academic impact, for papers by Heidrun Recheis Breakdown of academic impact, for papers by Timothy C. Rodell Breakdown of academic impact, for papers by Anna Vossenkämper
Rankless by CCL
2026